Shukla Sanjay
President And CEO
1 company
Insider Signal Score
66
StrongTrades Analyzed
12
12M Win Rate
58.3%
Avg 3M Return
+16.9%
Avg 12M Return
+25.2%
Shukla Sanjay is a President And CEO at aTYR PHARMA INC. Recent SEC Form 4 filings include 11 buys and 1 sell.
Estimated insider holdings value: $69K based on current market prices.
Holdings by Company
ATYRFeb 3, 2025
Current Shares146.9K
Value$69.1K
Net Activity+112.0K
Bought: 113.5KSold: 1.5K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | ATYR Atyr Pharma Inc | President And CEO | Buy | 20,000 | $1.81 | $36,140.00 | +17.2% | +9.2% | +158.4% | |
| Dec 12, 2023 | ATYR Atyr Pharma Inc | President And CEO | Buy | 15,000 | $1.18 | $17,646.00 | +8.1% | +34.5% | +166.4% | |
| Nov 13, 2023 | ATYR Atyr Pharma Inc | President And CEO | Buy | 15,000 | $1.11 | $16,703.39 | +9.8% | +76.7% | +213.0% | |
| Jul 28, 2023 | ATYR Atyr Pharma Inc | President And CEO | Buy | 15,000 | $2.01 | $30,223.50 | +24.5% | -38.8% | +10.4% | |
| Nov 21, 2022 | ATYR Atyr Pharma Inc | President And CEO | Buy | 10,000 | $2.14 | $21,405.00 | +24.5% | +1.9% | -46.5% | |
| Jul 1, 2022 | ATYR Atyr Pharma Inc | President And CEO | Buy | 15,000 | $2.88 | $43,164.00 | +58.1% | 0.0% | -24.2% | |
| Jan 7, 2022 | ATYR Atyr Pharma Inc | President And CEO | Buy | 5,000 | $6.76 | $33,806.50 | +24.0% | -22.5% | -63.0% | |
| Nov 15, 2021 | ATYR Atyr Pharma Inc | President And CEO | Buy | 2,500 | $8.58 | $21,437.50 | +13.7% | -40.1% | -71.3% | |
| May 18, 2021 | ATYR Atyr Pharma Inc | President And CEO | Buy | 10,000 | $4.01 | $40,100.00 | +120.5% | +18.4% | -24.2% | |
| Feb 9, 2021 | ATYR Atyr Pharma Inc | President And CEO | Sale+OE | 778 | $7.66 | $5,959.48 | -8.6% | -50.3% | -21.4% |
Page 1Next →